Skip to content
Brand AI

RenBio (United States)

Recent events

Recent events tied to this brand in public sources.

Back to profile2 entries

  1. 2021

    RenBio licenses Columbia University's RB-100 antibody

    RenBio signed a license agreement with Columbia University granting RenBio exclusive worldwide development and commercialization rights to the RB-100 bispecific antibody for COVID-19.

    Source

  2. 2021

    RenBio completes $24 million Series A financing

    RenBio announced that it completed a $24 million Series A financing led by Taiwan-based Ruentex Group.

    Source